{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:39:13Z","timestamp":1775975953081,"version":"3.50.1"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.reumae.2025.501891","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:35:07Z","timestamp":1751650507000},"page":"501891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ocular inflammatory manifestations in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"21","author":[{"given":"Raul E.","family":"Ruiz-Lozano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Arnaldo","family":"Prida-Espaillat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinaldo A.","family":"Moll-Auais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia M.","family":"Ramos-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel E.","family":"Quiroga-Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Khodor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Almobayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vega-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Rodriguez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.501891_bib0755","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00296-017-3769-3","article-title":"Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis","volume":"37","author":"Galarza-Delgado","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2025.501891_bib0760","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-023-06628-2","article-title":"Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019","volume":"42","author":"Shi","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0765","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5114\/aoms.2017.71371","article-title":"Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study","volume":"15","author":"Batko","year":"2019","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.reumae.2025.501891_bib0770","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/diseases5040027","article-title":"Development of evidence-based disease education literature for Pakistani rheumatoid arthritis patients","volume":"5","author":"Naqvi","year":"2017","journal-title":"Diseases"},{"key":"10.1016\/j.reumae.2025.501891_bib0775","doi-asserted-by":"crossref","first-page":"101477","DOI":"10.1016\/j.berh.2019.101477","article-title":"The epidemiology of established rheumatoid arthritis","volume":"33","author":"Oton","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0780","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3899\/jrheum.100951","article-title":"Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology","volume":"86","author":"Pelaez-Ballestas","year":"2011","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.reumae.2025.501891_bib0785","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2025.501891_bib0790","doi-asserted-by":"crossref","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2025.501891_bib0795","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15344\/2456-8007\/2019\/139","article-title":"Ocular manifestations of rheumatoid arthritis: implications of recent clinical trials","volume":"4","author":"Bhamra","year":"2019","journal-title":"Int J Clin Res Trials"},{"key":"10.1016\/j.reumae.2025.501891_bib0800","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3899\/jrheum.190768","article-title":"Ocular manifestations in rheumatoid arthritis connective tissue disease, and vasculitis: a systematic review and metaanalysis","volume":"48","author":"Turk","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0805","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10792-019-01183-9","article-title":"Ocular manifestations of rheumatic diseases","volume":"40","author":"Kemeny-Beke","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib0810","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/bjophthalmol-2022-321132","article-title":"Rheumatoid arthritis-associated peripheral ulcerative keratitis outcomes after early immunosuppressive therapy","volume":"107","author":"Ruiz-Lozano","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib0815","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00296-020-04568-7","article-title":"Analysis of ocular surface damage and visual impact in patients with primary and secondary Sjogren syndrome","volume":"40","author":"Villarreal-Gonzalez","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2025.501891_bib0820","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis Effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib0825","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib0830","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10067-017-3551-7","article-title":"Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015\/2016 recommendations for cardiovascular risk management","volume":"36","author":"Galarza-Delgado","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0835","doi-asserted-by":"crossref","first-page":"501813","DOI":"10.1016\/j.reuma.2024.501813","article-title":"Comorbidities in Mexican Mestizo patients with rheumatoid arthritis: a cross-sectional study of 523 patients in a preventive cardio-rheumatology clinic","volume":"21","author":"Arvizu-Rivera","year":"2025","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.reumae.2025.501891_bib0840","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3899\/jrheum.150166","article-title":"A study of multiple causes of death in rheumatoid arthritis","volume":"42","author":"Pinheiro","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0845","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12890-021-01569-5","article-title":"Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns","volume":"21","author":"Nieto","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.reumae.2025.501891_bib0850","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s10067-019-04668-1","article-title":"Clinicopathologic features of rheumatoid nodules: a retrospective analysis","volume":"38","author":"Bang","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0855","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00296-020-04591-8","article-title":"Anxiety and depression in reproductive age women with rheumatic diseases","volume":"40","author":"Skinner-Taylor","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2025.501891_bib0860","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1573397115666191007121605","article-title":"Etiological features of liver involvement in rheumatoid arthritis","volume":"16","author":"Sellami","year":"2020","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.reumae.2025.501891_bib0865","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rdc.2017.09.005","article-title":"Gastrointestinal and hepatic disease in rheumatoid arthritis","volume":"44","author":"Craig","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.reumae.2025.501891_bib0870","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10792-021-02058-8","article-title":"Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review","volume":"42","author":"Dammacco","year":"2022","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib0875","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.ico.0000177838.38873.2f","article-title":"Mucins and contact lens wear","volume":"25","author":"Hori","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.reumae.2025.501891_bib0880","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jtos.2020.09.007","article-title":"The molecular basis of neurotrophic keratopathy: diagnostic and therapeutic implications. A review","volume":"19","author":"Ruiz-Lozano","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.reumae.2025.501891_bib0885","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/OPX.0b013e31829962ec","article-title":"Effect of incomplete blinking on tear film stability","volume":"90","author":"Hirota","year":"2013","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.reumae.2025.501891_bib0890","doi-asserted-by":"crossref","first-page":"183300","DOI":"10.1016\/j.bbamem.2020.183300","article-title":"Mixed polar-nonpolar lipid films as minimalistic models of Tear Film Lipid Layer: a Langmuir trough and fluorescence microscopy study","volume":"1862","author":"Olzynska","year":"2020","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.reumae.2025.501891_bib0895","doi-asserted-by":"crossref","first-page":"14054","DOI":"10.1038\/s41598-020-70944-9","article-title":"Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker","volume":"10","author":"Usuba","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2025.501891_bib0900","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000487487","article-title":"Meibomian gland dysfunction in primary and secondary Sjogren syndrome","volume":"59","author":"Sullivan","year":"2018","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.reumae.2025.501891_bib0905","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/s41433-023-02447-6","article-title":"Corneal nerve loss and increased Langerhans cells are associated with disease severity in patients with rheumatoid arthritis","volume":"37","author":"Bitirgen","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.reumae.2025.501891_bib0910","first-page":"e34127","article-title":"Rheumatoid neuropathy: a brief overview","volume":"15","author":"Rajeshwari","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.reumae.2025.501891_bib0915","first-page":"20","article-title":"Ocular manifestations of rheumatoid arthritis","volume":"25","author":"Reddy","year":"1977","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib0920","first-page":"134","article-title":"Ocular manifestations of rheumatoid arthritis","volume":"87","author":"Bhadoria","year":"1989","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.reumae.2025.501891_bib0925","first-page":"203","article-title":"Sjogren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study","volume":"7","author":"Andonopoulos","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0930","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01816435","article-title":"Ocular complications of adult rheumatoid arthritis","volume":"16","author":"Reddy","year":"1996","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2025.501891_bib0935","first-page":"2615","article-title":"Role of opticare eye drop delivery system in patients with rheumatoid arthritis","volume":"26","author":"Averns","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0940","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.58.7.415","article-title":"Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis","volume":"58","author":"Uhlig","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib0945","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/PL00006853","article-title":"Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis","volume":"19","author":"Cimmino","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2025.501891_bib0950","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.60.12.1103","article-title":"Sicca symptoms and secondary Sjogren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables","volume":"60","author":"Gilboe","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib0955","first-page":"537","article-title":"Rheumatoid arthritis and ocular involvement","volume":"101","author":"Shaw","year":"2003","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.reumae.2025.501891_bib0960","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.10999","article-title":"A prospective study of sicca symptoms in patients with rheumatoid arthritis","volume":"49","author":"Brun","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501891_bib0965","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/ard.62.9.897","article-title":"Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity","volume":"62","author":"Carmona","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib0970","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib0975","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ajo.2005.05.025","article-title":"Correlation between dry eye and rheumatoid arthritis activity","volume":"140","author":"Fujita","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib0980","first-page":"305","article-title":"Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey","volume":"24","author":"Calguneri","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib0985","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/09286580600745969","article-title":"Rheumatoid arthritis is a risk factor for dry eye in the Indian population","volume":"13","author":"Punjabi","year":"2006","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.reumae.2025.501891_bib0990","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1590\/S0004-27492008000300011","article-title":"Prevalence of ocular manifestation in 198 patients with rheumatoid arthritis: a retrospective study","volume":"71","author":"Bettero","year":"2008","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib0995","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1185\/030079908X261177","article-title":"The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006","volume":"24","author":"Hochberg","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.reumae.2025.501891_bib1000","doi-asserted-by":"crossref","first-page":"323","DOI":"10.17305\/bjbms.2010.2680","article-title":"Ocular manifestation of rheumatoid arthritis-different forms and frequency","volume":"10","author":"Zlatanovic","year":"2010","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.reumae.2025.501891_bib1005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10067-011-1678-5","article-title":"Demographic, clinical, and serological features of Turkish patients with rheumatoid arthritis: evaluation of 165 patients","volume":"30","author":"Kobak","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1010","first-page":"713","article-title":"Ocular involvement and its\u2019 manifestations in rheumatoid arthritis patients","volume":"150","author":"Markovitz","year":"2011","journal-title":"Harefuah"},{"key":"10.1016\/j.reumae.2025.501891_bib1015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00296-011-1822-1","article-title":"Extraarticular manifestations in Turkish patients with rheumatoid arthritis: impact of EAMs on the health-related quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning","volume":"32","author":"Eser","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2025.501891_bib1020","first-page":"39","article-title":"Ocular manifestations in rheumatoid arthritis: 24 cases in Abidjan","volume":"29","author":"Kouakou","year":"2014","journal-title":"Mali Med"},{"key":"10.1016\/j.reumae.2025.501891_bib1025","first-page":"393","article-title":"Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies","volume":"9","author":"Vignesh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/09273948.2016.1212078","article-title":"Ophthalmic manifestations in chronic inflammatory rheumatic diseases at a referral hospital of Yaounde Cameroon","volume":"26","author":"Domngang Noche","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.reumae.2025.501891_bib1035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/DJO.DJO_17_17","article-title":"Ocular involvement and its manifestations in rheumatoid arthritis patients","volume":"18","author":"Aboud","year":"2017","journal-title":"Delta J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3899\/jrheum.170437","article-title":"Clinical correlates outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era","volume":"45","author":"Caimmi","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1045","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10792-018-0902-6","article-title":"The impact of ocular manifestations of rheumatoid arthritis on the health-related quality of life and the functional ability of black Africans","volume":"39","author":"Akintayo","year":"2019","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semarthrit.2020.01.004","article-title":"Prevalence and clinical significance of extra-articular manifestations at diagnosis in the ESPOIR cohort with recent-onset arthritis","volume":"50","author":"Guellec","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501891_bib1055","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.2147\/OPTH.S306621","article-title":"Ocular manifestations in Colombian patients with systemic rheumatologic diseases","volume":"15","author":"Uribe-Reina","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1060","first-page":"481","article-title":"Ocular findings in rheumatoid arthritis: retrospective study","volume":"14","author":"Cetinkaya","year":"2022","journal-title":"Konuralp Med J"},{"key":"10.1016\/j.reumae.2025.501891_bib1065","first-page":"20","article-title":"Rheumatoid arthritis associated with dry eye disease and corneal surface damage: a nationwide matched cohort study","author":"Lai","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.reumae.2025.501891_bib1070","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/09273948.2022.2079532","article-title":"Combined Ophthalmology and Rheumatology evaluation in systemic autoimmune diseases with ocular involvement: a third level reference center in Mexico","volume":"31","author":"Baquero-Ospina","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.reumae.2025.501891_bib1075","doi-asserted-by":"crossref","DOI":"10.1177\/11206721221088259","article-title":"Dry eye disease, a prominent manifestation of systemic autoimmune disorders","author":"Bustamante-Arias","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sjogren's syndrome: a systemic autoimmune disease","volume":"22","author":"Negrini","year":"2022","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.reumae.2025.501891_bib1085","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/1756-185X.13889","article-title":"Cognitive dysfunction in Sjogren's syndrome using the Montreal Cognitive Assessment Questionnaire and the Automated Neuropsychological Assessment Metrics: a cross-sectional study","volume":"23","author":"Riega-Torres","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib1090","doi-asserted-by":"crossref","first-page":"105502","DOI":"10.1016\/j.jbspin.2022.105502","article-title":"Non-primary Sjogren's Syndrome: secondary or associated?","volume":"90","author":"Felten","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.reumae.2025.501891_bib1095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.reumae.2025.501891_bib1100","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.reumae.2025.501891_bib1105","doi-asserted-by":"crossref","first-page":"5768679","DOI":"10.1155\/2020\/5768679","article-title":"Study of factors influencing dry eye in rheumatoid arthritis","volume":"2020","author":"Ma","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1110","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrrheum.2014.85","article-title":"The eye: a window of opportunity in rheumatoid arthritis?","volume":"10","author":"Tong","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1115","first-page":"448","article-title":"Secondary Sjogren's syndrome in 83 patients with rheumatoid arthritis","volume":"54","author":"Hajiabbasi","year":"2016","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.reumae.2025.501891_bib1120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1753425912471692","article-title":"Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study","volume":"19","author":"Villani","year":"2013","journal-title":"Innate Immun"},{"key":"10.1016\/j.reumae.2025.501891_bib1125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.reumae.2025.501891_bib1130","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","article-title":"Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis","volume":"176","author":"Niederkorn","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.reumae.2025.501891_bib1135","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/ICO.0000000000000257","article-title":"Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis","volume":"33","author":"Schargus","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.reumae.2025.501891_bib1140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000099254","article-title":"Corneal antigen-presenting cells","volume":"92","author":"Hamrah","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.reumae.2025.501891_bib1145","first-page":"70","article-title":"Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege","volume":"39","author":"Dana","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.reumae.2025.501891_bib1150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2017.10.001","article-title":"Neuropathic pain and dry eye","volume":"16","author":"Galor","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.reumae.2025.501891_bib1155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","article-title":"A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry","volume":"149","author":"Whitcher","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42358-022-00255-2","article-title":"Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome","volume":"62","author":"de Oliveira","year":"2022","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1165","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2147\/OPTH.S351898","article-title":"A practical approach to severity classification and treatment of dry eye disease: a proposal from the Mexican dry eye disease expert panel","volume":"16","author":"Rodriguez-Garcia","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.reumae.2025.501891_bib1175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/ICO.0000000000001227","article-title":"Comparison of tear osmolarity in rheumatoid arthritis patients with and without secondary Sjogren Syndrome","volume":"36","author":"Ng","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.reumae.2025.501891_bib1180","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.53.10.637","article-title":"Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome","volume":"53","author":"Vitali","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib1185","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3341\/kjo.2022.0006","article-title":"The repeatability reproducibility, and correlation of the Schirmer test: a comparison of open versus closed eye","volume":"36","author":"Ekici","year":"2022","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/acr2.1033","article-title":"Reproducibility of ocular surface staining in the assessment of Sjogren syndrome-related keratoconjunctivitis sicca: implications on disease classification","volume":"1","author":"Rasmussen","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1195","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ophtha.2021.03.030","article-title":"Systemic conditions associated with severity of dry eye signs and symptoms in the dry eye assessment and management study","volume":"128","author":"Yu","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1200","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bjo.86.8.879","article-title":"Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients","volume":"86","author":"Aragona","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1205","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.rbr.2015.07.004","article-title":"Recommendations for the treatment of Sjogren's syndrome","volume":"55","author":"Valim","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1210","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11596-008-0523-9","article-title":"A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes","volume":"28","author":"Xiao","year":"2008","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"10.1016\/j.reumae.2025.501891_bib1215","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1038\/s41598-017-08534-5","article-title":"Sodium hyaluronate in the treatment of dry eye syndrome: a systematic review and meta-analysis","volume":"7","author":"Ang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2025.501891_bib1220","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/eye.2015.125","article-title":"Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjogren's syndrome","volume":"29","author":"Yokoi","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.reumae.2025.501891_bib1225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/jop.2015.0081","article-title":"The efficacy of diquafosol ophthalmic solution in non-Sjogren and Sjogren syndrome dry eye patients unresponsive to artificial tear","volume":"32","author":"Jeon","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.reumae.2025.501891_bib1230","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/eye.2016.54","article-title":"The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjogren's syndrome: a pilot study","volume":"30","author":"Yokoi","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.reumae.2025.501891_bib1235","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00417-022-05840-1","article-title":"Short-term results of a pulsed therapy with hydrocortisone eye drops to treat moderate to severe dry eye in primary Sjogren syndrome patients","volume":"261","author":"Menchini","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1240","doi-asserted-by":"crossref","first-page":"7584370","DOI":"10.1155\/2021\/7584370","article-title":"Efficacy of topical hydrocortisone in combination with topical ciclosporin a for the treatment of dry eye disease in patients with Sjogren syndrome","volume":"2021","author":"Fondi","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1245","doi-asserted-by":"crossref","first-page":"165","DOI":"10.51329\/mehdiophthal1435","article-title":"Update on indications, complications, and outcomes of scleral contact lenses","volume":"10","author":"Ruiz-Lozano","year":"2021","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1250","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajo.2008.06.003","article-title":"Bacteriologic profile of the conjunctiva in the patients with dry eye","volume":"146","author":"Hori","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1255","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/bjo.2008.154468","article-title":"Microbiological and clinical profiles of patients with microbial keratitis residing in nursing homes","volume":"93","author":"Jhanji","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jtos.2012.12.002","article-title":"Dry eye disease and microbial keratitis: is there a connection?","volume":"11","author":"Narayanan","year":"2013","journal-title":"Ocul Surf"},{"key":"10.1016\/j.reumae.2025.501891_bib1265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/20009666.2017.1418110","article-title":"Is this a worrisome red eye? Episcleritis in the primary care setting","volume":"8","author":"Salama","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.reumae.2025.501891_bib1280","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0161-6420(99)90157-4","article-title":"Severity of episcleritis and systemic disease association","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1285","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.60.3.192","article-title":"Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis","volume":"60","author":"McGavin","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1295","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1300","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0161-6420(94)31325-X","article-title":"Severity of scleritis and episcleritis","volume":"101","author":"Sainz de la Maza","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1305","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.survophthal.2020.12.008","article-title":"The clinical and pathogenic spectrum of surgically-induced scleral necrosis: a review","volume":"66","author":"Ruiz-Lozano","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1310","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(91)32280-2","article-title":"Immunopathology of scleritis","volume":"98","author":"Fong","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1315","doi-asserted-by":"crossref","first-page":"103391","DOI":"10.1016\/j.autrev.2023.103391","article-title":"Rheumatoid vasculitis in 2023: changes and challenges since the biologics era","volume":"22","author":"Mertz","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2025.501891_bib1320","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/jcm10102118","article-title":"Rheumatoid arthritis associated episcleritis and scleritis: an update on treatment perspectives","volume":"10","author":"Promelle","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.reumae.2025.501891_bib1325","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0161-6420(91)32062-1","article-title":"Necrotizing scleritis after ocular surgery. A clinicopathologic study","volume":"98","author":"Sainz de la Maza","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10384-019-00674-7","article-title":"Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis)","volume":"63","author":"Yoshida","year":"2019","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1335","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1340","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","article-title":"Scleritis associated with systemic vasculitic diseases","volume":"102","author":"Sainz de la Maza","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501891_bib1350","doi-asserted-by":"crossref","first-page":"102020","DOI":"10.1016\/j.berh.2024.102020","article-title":"Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up","volume":"39","author":"Misra","year":"2025","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1355","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0161-6420(85)33822-8","article-title":"Necrotizing scleritis. A clinico-pathologic study of 41 cases","volume":"92","author":"Rao","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1360","first-page":"23","article-title":"Immunopathological analysis of a mouse model of arthritis-associated scleritis and implications for molecular targeted therapy for severe scleritis","author":"Nishio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.reumae.2025.501891_bib1365","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/ceo.13709","article-title":"Ocular complications and mortality in peripheral ulcerative keratitis and necrotising scleritis: the role of systemic immunosuppression","volume":"48","author":"Ogra","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1370","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1375","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3174\/ajnr.A4890","article-title":"CT and MR imaging in the diagnosis of scleritis","volume":"37","author":"Diogo","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.reumae.2025.501891_bib1380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1442-9071.1988.tb01206.x","article-title":"Current concepts in the management of scleritis","volume":"16","author":"McCluskey","year":"1988","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1385","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000486791","article-title":"Cyclophosphamide or rituximab treatment of scleritis and uveitis for patients with granulomatosis with polyangiitis","volume":"61","author":"Ahmed","year":"2019","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.reumae.2025.501891_bib1390","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.73.9.743","article-title":"Cyclosporin therapy for severe scleritis","volume":"73","author":"Wakefield","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2011.07.043","article-title":"Scleritis therapy","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1400","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0161-6420(94)31178-X","article-title":"Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases","volume":"101","author":"Sainz de la Maza","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1405","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.survophthal.2021.02.013","article-title":"Peripheral ulcerative keratitis","volume":"66","author":"Gupta","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1410","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10792-013-9879-3","article-title":"Peripheral ulcerative keratitis as the presenting feature of systemic rheumatoid vasculitis without joint involvement","volume":"34","author":"Morgan-Warren","year":"2014","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1415","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.survophthal.2023.02.009","article-title":"Wessely corneal ring phenomenon: an unsolved pathophysiological dilemma","volume":"68","author":"Ruiz-Lozano","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1420","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/rheumatology\/38.12.1245","article-title":"Peripheral ulcerative keratitis \u2018corneal melt\u2019 and rheumatoid arthritis: a case series","volume":"38","author":"Squirrell","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2025.501891_bib1425","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/eye.1995.182","article-title":"Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis","volume":"9","author":"Riley","year":"1995","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.reumae.2025.501891_bib1430","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/bjo.83.12.1376","article-title":"Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis","volume":"83","author":"Smith","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1435","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","article-title":"Scleritis and peripheral ulcerative keratitis","volume":"33","author":"Galor","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.reumae.2025.501891_bib1440","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/BOR.0b013e328337b832","article-title":"Patient-tailored therapy in rheumatoid arthritis: an editorial review","volume":"22","author":"Scherer","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501891_bib1445","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5935\/0004-2749.202100108","article-title":"Acute postoperative paracentral corneal melting and perforation after uncomplicated cataract surgery in a patient with inadvertent rheumatoid arthritis","volume":"84","author":"Rodriguez-Garcia","year":"2021","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1450","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10792-017-0545-z","article-title":"Corneal melting in rheumatoid arthritis patients treated with a tectonic reinforcing corneolimbal graft: an interventional case series","volume":"38","author":"Livny","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1455","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1756-185X.12688","article-title":"Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review","volume":"20","author":"Watanabe","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501891_bib1460","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/112067210601600602","article-title":"Rheumatoid keratolysis: a series of 40 eyes","volume":"16","author":"Malik","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1465","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225428","article-title":"Corneal perforation in undiagnosed Sjogren's syndrome following topical NSAID and steroid drops post routine cataract extraction","volume":"2018","author":"Murtagh","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.reumae.2025.501891_bib1470","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/bjo.66.3.179","article-title":"Sterile corneal perforation after cataract surgery in Sjogren's syndrome","volume":"66","author":"Cohen","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1475","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0161-6420(92)32006-8","article-title":"Paracentral rheumatoid corneal ulceration Clinical features and cyclosporine therapy","volume":"99","author":"Kervick","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.reumae.2025.501891_bib1480","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bjo.87.5.548","article-title":"Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations","volume":"87","author":"Prada","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archopht.1978.03910050015003","article-title":"Sterile corneal ulcers after cataract surgery in keratoconjunctivitis sicca","volume":"96","author":"Radtke","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archopht.1980.01020030091006","article-title":"Corneal ulceration and perforation associated with Sjogren's syndrome","volume":"98","author":"Pfister","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1495","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12886-016-0339-5","article-title":"The effects of oral and topical corticosteroid in rabbit corneas","volume":"16","author":"Araki-Sasaki","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.reumae.2025.501891_bib1500","first-page":"87","article-title":"Acute corneal melting one week after an uncomplicated cataract surgery in a patient who previously underwent eyelid radiation and with undiagnosed rheumatoid arthritis: a case report","volume":"84","author":"Dervenis","year":"2021","journal-title":"Arq Bras Oftalmol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:44:41Z","timestamp":1751651081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574325000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2173574325000759"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501891","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular inflammatory manifestations in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501891"}}